Showing results (91-100 of 979) with videos related to
Sort By:
Pageof 98
Current Drug Safety|March 10, 2010
Technology utilization to prevent medication errorsAllison Forni, Hanh T Chu, John FanikosCurrent Drug Safety|March 10, 2010
Mechanisms of drug induced QT interval prolongationMarcelo Luis Ponte, Guillermo Alberto Keller, Guillermo Di GirolamoCurrent Drug Safety|March 10, 2010
Endocrine therapies and QTc prolongationClaudio Daniel Gonzalez, Martha de Sereday, Isaac Sinay, et al.Current Drug Safety|March 10, 2010
Antineoplastic chemotherapy induced QTc prolongationClaudia Bagnes, Patricia Natalia Panchuk, Gonzalo RecondoCurrent Drug Safety|March 10, 2010
Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazoneR Simó, A Rodriguez, E CavedaCurrent Drug Safety|April 7, 2018
Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in ChildrenMiia Artama, Hanna Rinta-Kokko, Hanna Nohynek, et al.Current Drug Safety|June 2, 2018
Risk and Benefit Profile of Dulaglutide in Established Therapeutic IndicationAakriti Garg, Anoop KumarCurrent Drug Safety|June 6, 2018
Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal EffectsJohn Read, James WilliamsCurrent Drug Safety|May 16, 2009
Determination of the frequency and direct cost of the adverse drug events in ArgentinaEstela Izquierdo, Claudio Rodríguez, Eneas Pampliega, et al.Current Drug Safety|May 16, 2009
Predictors of "worsening renal function" in patients hospitalized in internal medicine departmentWaleed M Sweileh, Ansam F Sawalha, Hanadi M Jayousi, et al.Pageof 98